arrow
M

Mariabeatrice Principi

azienda policlinico-universitaria di bari and university of bari
H指数:37
被引数:4,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of low volume versus high-volume polyethylene glycol-based bowel preparation for colonoscopy in people receiving haemodialysis: a randomized non-inferiority trial

低容量与高容量聚乙二醇基肠道准备在结肠镜检查中的比较:一项针对血液透析患者的随机非劣效性试验

2026-10-150
PRE
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)

真实世界中乌帕替尼在克罗恩病患者中的有效性和安全性——一项来自意大利炎症性肠病研究组(IG-IBD)的多中心前瞻性研究

2026-09-110
PRE
IBD impact on quality of life and perception of disease activity in Italian patients and physicians: An IBD-PODCAST study sub analysis

IBD对意大利患者和医生生活质量及疾病活动度感知的影响:IBD-PODCAST研究的子分析

2025-06-140
OAAI
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study

Vedolizumab在炎症性肠病中的真实世界结局及其机器学习预测——IG-IBD LIVE研究

2025-05-120
PRE
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)

托法替尼和 vedolizumab 作为抗-TNFs 后溃疡性结肠炎的二线治疗的真实世界有效性与安全性:一项多中心队列 IGIBD 研究(VE2TO-UC)

2025-05-060
PRE
Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD)
2025-01-220
PRE
Effectiveness and safety of Risankizumab in Crohn's disease patients from a large Italian cohort: preliminary results from the RESOLVE IgIBD study
2025-01-220
PRE
Apulian Network for Inflammatory Bowel Disease (AN-IBD) safety profile: Pilot data
2025-01-220
PRE
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study
2025-01-010
OAAI
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)
2024-09-012
PRE
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study
2024-05-010
OAAI